Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Fullstone

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2023
Rapid Particle-Based Simulations of Cellular Signalling with the FLAME-Accelerated Signalling Tool (FaST) and GPUsGavin Fullstone
Scientific Reports|June 11, 2015
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based ApproachGavin Fullstone, Jonathan Wood, Mike Holcombe, et al.
NPJ Systems Biology and Applications|April 22, 2020
The FLAME-accelerated signalling tool (FaST) for facile parallelisation of flexible agent-based models of cell signallingGavin Fullstone, Cristiano Guttà, Amatus Beyer, et al.
Cell Death & Disease|December 19, 2025
Stochasticity contributes to explaining minority and majority MOMP during apoptosisJenny Geiger, Fabian Klötzer, Nadine Pollak, et al.
Cell Death and Differentiation|April 29, 2020
The apoptosome molecular timer synergises with XIAP to suppress apoptosis execution and contributes to prognosticating survival in colorectal cancerGavin Fullstone, Tabea L Bauer, Cristiano Guttà, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of GlioblastomaNivetha Krishna Moorthy, Oliver Seifert, Stephan Eisler, et al.
Cell Death & Disease|June 25, 2021
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonistChiara Boccellato, Emily Kolbe, Nathalie Peters, et al.
Science Advances|August 8, 2017
Chemotactic synthetic vesicles: Design and applications in blood-brain barrier crossingAdrian Joseph, Claudia Contini, Denis Cecchin, et al.
Mabs|September 22, 2025
A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriersPhilipp Kuhn, Sabrina Petralla, Fatemeh Dabbagh, et al.
Cell Death and Differentiation|May 21, 2020
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroidsDaniela Stöhr, Jens O Schmid, Tobias B Beigl, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|April 19, 2023
Rapid Particle-Based Simulations of Cellular Signalling with the FLAME-Accelerated Signalling Tool (FaST) and GPUsGavin Fullstone
Scientific Reports|June 11, 2015
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based ApproachGavin Fullstone, Jonathan Wood, Mike Holcombe, et al.
NPJ Systems Biology and Applications|April 22, 2020
The FLAME-accelerated signalling tool (FaST) for facile parallelisation of flexible agent-based models of cell signallingGavin Fullstone, Cristiano Guttà, Amatus Beyer, et al.
Cell Death & Disease|December 19, 2025
Stochasticity contributes to explaining minority and majority MOMP during apoptosisJenny Geiger, Fabian Klötzer, Nadine Pollak, et al.
Cell Death and Differentiation|April 29, 2020
The apoptosome molecular timer synergises with XIAP to suppress apoptosis execution and contributes to prognosticating survival in colorectal cancerGavin Fullstone, Tabea L Bauer, Cristiano Guttà, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Low-Level Endothelial TRAIL-Receptor Expression Obstructs the CNS-Delivery of Angiopep-2 Functionalised TRAIL-Receptor Agonists for the Treatment of GlioblastomaNivetha Krishna Moorthy, Oliver Seifert, Stephan Eisler, et al.
Cell Death & Disease|June 25, 2021
Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonistChiara Boccellato, Emily Kolbe, Nathalie Peters, et al.
Science Advances|August 8, 2017
Chemotactic synthetic vesicles: Design and applications in blood-brain barrier crossingAdrian Joseph, Claudia Contini, Denis Cecchin, et al.
Mabs|September 22, 2025
A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriersPhilipp Kuhn, Sabrina Petralla, Fatemeh Dabbagh, et al.
Cell Death and Differentiation|May 21, 2020
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroidsDaniela Stöhr, Jens O Schmid, Tobias B Beigl, et al.
Pageof 2